Ista Anticipates Bepotastine NDA Filing In 2007 For Allergic Conjunctivitis
This article was originally published in The Pink Sheet Daily
Executive Summary
The ophthalmic company licensed the investigational eye drop formulation from Senju for $6 mil. in up-front and potential milestone payments.